Sarcopenic skeletal muscles are known to be insulin resistant even in the setting of low whole-body fat stores [70], and considering that skeletal muscle is a primary site of both insulin action and glucose uptake/storage [71–75], sarcopenia contributes significantly to systemic metabolic syndrome [76]. Here, INS is linked to sarcopenia.